Hemab Therapeutics Holdings, Inc.
44.50USD
-0.0700 (-0.16%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.51▼ | $0 | 0 | 2 |
| Next quarter | $-0.57▼ | $0 | 2 | 1 |
| Current year | $-3.1▼ | $0 | 1 | 2 |
| Next year | $-2.54▼ | $0 | 1 | 2 |
Beat in 1 of the last 1
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.82 | $-0.8 | +0.02 (+2.0%) |
11 ratings from 5 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Wedbush | Maintained | Outperform | $55 $64 | Aug 12, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $52 $60 | Aug 11, 2026 |
| Jefferies | Maintained | Buy | $39 $47 | Jul 13, 2026 |
| Wedbush | Maintained | Outperform | $42 $55 | Jul 13, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $40 $52 | Jul 13, 2026 |
| HC Wainwright & Co. | Reiterated | Buy | $40 | Jun 26, 2026 |
| HC Wainwright & Co. | Initiated | Buy | $40 | Jun 17, 2026 |
| Wedbush | Initiated | Outperform | $42 | May 26, 2026 |
| Jefferies | Initiated | Buy | $39 | May 26, 2026 |
| Evercore ISI Group | Initiated | Outperform | $50 | May 26, 2026 |
| Goldman Sachs | Initiated | Buy | $36 | May 26, 2026 |
8 filings from 4 insiders · 0 buy / 0 sell over 6m
Officers and directors of COAG, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 67.7k | $24.89 | $1.69M | Jun 16, 2026 |
| RA CAPITAL MANAGEMENT, L.P.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 4.8k | $24.94 | $120k | May 20, 2026 |
| RA CAPITAL HEALTHCARE FUND,L.P.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 6.4k | $24.90 | $159k | May 12, 2026 |
| RA CAPITAL HEALTHCARE FUND,L.P.Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 51.3k | $24.34 | $1.27M | May 11, 2026 |
| RA CAPITAL HEALTHCARE FUND,L.P.Director and Beneficial Owner of more than 10% of a Class of Security | Buyindirect | 2.84M | $23.77 | $71.86M | May 6, 2026 |
| MARAGANORE JOHN MDirector | Other | 35.9k | — | — | May 4, 2026 |
| NOVO HOLDINGS A/SBeneficial Owner of more than 10% of a Class of Security | Other | 4.18M | — | — | May 4, 2026 |
| RA CAPITAL HEALTHCARE FUND,L.P.Director and Beneficial Owner of more than 10% of a Class of Security | Otherindirect | 4.84M | — | — | May 4, 2026 |
No analyst notes on COAG yet.
Analyst Ratings
5 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 0 | 5 | 0 | 0 | 0 | Buy2.00 |
| 1 mo ago | 0 | 5 | 0 | 0 | 0 | Buy2.00 |
| 2 mo ago | 0 | 5 | 0 | 0 | 0 | Buy2.00 |